Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem[4] Imipenem,
Meropenem,
Methylprednisolone,
Ursodeoxycholic acid		[7] Imipenem ,
Methylprednisolone ,
Ursodiol ,
Methylprednisolone acetate ,
Meropenem ,
Imipenem ,
Meropenem 💬 		[2] NR1H4,
NR3C1 💬 		[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
2Dietary Supplement: vitamin A[1] Vitamin A (Vitamin A1)[2] Vitamin A oil (Vitamin A oil),
Vitamin A (Vitamin A, Vitamin A1) 💬 		[2] RARA,
RARB 💬 		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 13 💬
3Vitamin A[1] Vitamin A (Vitamin A1)[2] Vitamin A oil (Vitamin A oil),
Vitamin A (Vitamin A, Vitamin A1) 💬 		[2] RARA,
RARB 💬 		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 13, 53, 90, 97 💬
4Vitamin AD sig: 1 tablet/tid----[1] 90 💬